Is seminal vesiculectomy included within the prostatectomy code?
For CPT 55866, it is typical to remove the seminal vesicles as part of procedure.
PSMA and MRI for early prostate cancer detection
Experts weigh in on whether the combined technologies could be the future power couple of prostate cancer diagnosis.
Call it by any name: Bladder that does not work
"As we look back over the past 5 decades in urology, bladder dysfunction, particularly inadequate contraction, is still a disorder with unmet medical need, for which new treatments are crucial," writes Gopal H. Badlani, MD.
How to use life insurance to pay estate taxes
Irrevocable life insurance trusts can be used to pay all or a portion of estate taxes.
FDA grants priority review to olaparib/abiraterone combo for mCRPC
The application is supported by the phase 3 PROpel trial, which showed that adding olaparib to frontline abiraterone acetate and prednisone/prednisolone significantly improved radiographic progression-free survival in patients with mCRPC.
Do 5-ARIs protect against death from prostate cancer?
"It is evident...that the safety of 5-ARIs as it relates to prostate cancer outcomes is contingent upon the clinician understanding its effect on PSA level and making appropriate adjustments to ensure timely deployment of diagnostic imaging and biopsy," writes Badar M. Mian, MD.
FDA clears path for trial of AI-enabled focal therapy in prostate cancer
The Avenda system combines the company’s proprietary iQuest AI-based margin prediction software algorithms with its FocalPoint laser ablation device.
Trial of novel abiraterone formulation for prostate cancer completes enrollment
The TAVT-45 formulation of abiraterone consists of granules for oral suspension and was created for patients with dysphagia who would have difficulty swallowing a tablet.
Are you seeing more health care workers planning to leave medicine?
"We’ve had no trouble recruiting because we focus on creating a positive culture with our team," says 1 urologist.
Radiation therapy for prostate cancer continues to evolve
In this installment of our 50th Anniversary Innovation Celebration, Anthony Zietman, MD, discusses the development of radiation therapy for prostate cancer.
2 Clarke Drive Cranbury, NJ 08512